461
Views
1
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Experiences with the use of oxaliplatin in esophageal carcinoma

, &
Pages 103-105 | Received 24 Aug 2005, Published online: 08 Jul 2009

Figures & data

Figure 1.  Treatment schedule.

Figure 1.  Treatment schedule.

Figure 2.  Time to progression (TTP) (a) and disease free survival (b).

Figure 2.  Time to progression (TTP) (a) and disease free survival (b).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.